Kalos Management, Inc. Boston Scientific Corp Transaction History

Kalos Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $1.12 Million - $1.98 Million	-43,327 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$37.87 - $45.37 $19,048 - $22,821	-503 Reduced 1.15%	43,327 $1.96 Million
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $512,219 - $552,119	12,707 Added 40.83%	43,830 $1.78 Million
Q2 2019 Aug 14, 2019	BUY	$34.91 - $42.98 $196,857 - $242,364	5,639 Added 22.13%	31,123 $1.1 Million
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $185,579 - $229,789	-5,639 Reduced 18.12%	25,484 $978,000
Q4 2018 Feb 13, 2019	BUY	$31.73 - $39.04 $9,994 - $12,297	315 Added 1.02%	31,123 $1.1 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $50,098 - $58,949	1,526 Added 5.21%	30,808 $1.19 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $785,928 - $1 Million	29,282 New	29,282 $957,000

1,539

1.19B

6.79M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.